Physician profile
Kelly Smith
NPI 1457690885
$1,340.60
in general payments reported to CMS, 2019-2025
20 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.29 · 2020: $18.93 · 2021: $98.38 · 2022: $198 · 2023: $73.68 · 2024: $477 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $352.35 | 2024-2025 | |
| Integra Lifesciences Corporation | $154.18 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $139.20 | 2022-2025 | Oasis, Grafix Pl, Oasis Micro |
| Baxter Healthcare | $113.07 | 2024 | Floseal |
| Organogenesis INC. | $78.90 | 2019-2024 | |
| Heron Therapeutics, INC. | $75.67 | 2021-2022 | |
| Advanced Oxygen Therapy INC. | $71.90 | 2020-2023 | Topical Oxygen Chamber For Extremities |
| Convatec INC. | $68.05 | 2025 | |
| Axogen | $51.09 | 2019-2022 | |
| Solventum Corporation | $40.04 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Activ.A.C. |
| Nevro Corp. | $31.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.50 | 2022-2023 | Seglentis |
| Tactile Systems Technology INC | $22.54 | 2024 | Entre Plus, Flexitouch Plus |
| Fidia Pharma USA INC. | $18.16 | 2024 | Hyalgan, Triluron, Hymovis |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.87 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $17.73 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $16.44 | 2024 | |
| Mimedx Group, INC. | $15.12 | 2025 | |
| Baudax Bio INC. | $14.73 | 2021 | |
| Bioventus LLC | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.